Antidepressants work by changing the levels of chemical messengers in your brain that regulate mood, sleep, energy, and motivation. The most commonly prescribed types increase the availability of serotonin, a neurotransmitter involved in emotional regulation, by preventing brain cells from reabsorbing it after it’s released. But the full picture is more complex than just “fixing a chemical imbalance,” and different classes of antidepressants work in meaningfully different ways.
How They Change Brain Chemistry
Your brain cells communicate by releasing chemical messengers called neurotransmitters into the tiny gaps between them. After a message is sent, the sending cell normally reabsorbs most of those molecules to recycle them. Antidepressants interrupt this recycling process, leaving more of the messenger available in that gap to keep signaling.
The most widely prescribed class, SSRIs, specifically blocks the transporter protein responsible for pulling serotonin back into the sending cell. By occupying the active site on that transporter, the drug prevents reabsorption and raises the amount of serotonin available between cells. Other classes target different messengers. SNRIs block the reabsorption of both serotonin and norepinephrine, a neurotransmitter involved in alertness and stress response. NDRIs increase norepinephrine and dopamine, which play roles in attention, motivation, and mood regulation.
Older antidepressants cast a wider net. Tricyclics act on serotonin and norepinephrine along with other brain chemicals, which makes them effective but also produces more side effects. MAO inhibitors work differently altogether: instead of blocking reabsorption, they prevent an enzyme from breaking down serotonin, norepinephrine, and other related messengers, allowing all of them to accumulate.
Beyond Serotonin: Effects on Brain Structure
Raising neurotransmitter levels happens within hours of taking a pill, yet mood improvements take longer to appear. This gap points to something deeper going on. Research published in Molecular Psychiatry found that antidepressants stimulate the growth of new brain cells in the hippocampus, a region critical for memory and emotional processing. In lab studies, the SSRI sertraline increased the number of mature neurons by 28% and triggered immature brain cells to begin developing into functional neurons, with a 16% increase in those early-stage cells.
This growth process depends on activating stress hormone receptors in a specific way and switching on genes that control cell development, including one that produces a protein called BDNF, which acts like fertilizer for brain cells. Newer glutamate-targeting treatments like esketamine appear to work through a similar endpoint: they boost BDNF release and strengthen the connections between neurons, increasing the brain’s ability to rewire itself. This process of structural remodeling, not just the chemical boost, may be what ultimately lifts depression.
How Quickly They Work
The conventional wisdom that antidepressants take four to six weeks to work is outdated. A meta-analysis of 76 placebo-controlled trials found that 60% of the total improvement seen at six weeks actually occurs within the first two weeks. One-third of the full effect is measurable in the first week alone. The pattern is one of rapid early gains followed by smaller, incremental improvements over the following weeks.
That said, early changes can be hard to interpret. Some people notice improved sleep or reduced physical tension before their mood lifts, and it can be difficult to separate genuine mood improvement from side effects like sedation. The clearest picture of whether a medication is working typically emerges by weeks two through four. If you’ve seen no change at all by that point, your prescriber will likely consider adjusting the dose or trying a different medication.
One notable exception: esketamine, a newer treatment derived from the anesthetic ketamine, can produce noticeable effects within hours. It works through an entirely different pathway, targeting glutamate receptors rather than serotonin, and has shown remission rates of 25 to 30% in people whose depression hadn’t responded to standard antidepressants. Its effects persist even after the drug clears the body, which allows it to be given intermittently rather than daily.
Common Side Effects
Between 60% and 75% of people taking antidepressants report at least one side effect, regardless of which medication they’re on. The two most common are reduced sex drive and weight gain. Other frequently reported effects include dry mouth, nausea, drowsiness, insomnia, dizziness, fatigue, excessive sweating, and headache. Less common but still notable are constipation, diarrhea, blurred vision, and anxiety or agitation, particularly in the early days of treatment.
Side effects are not evenly distributed across drug classes. SSRIs are more likely to cause sexual side effects and nausea. NDRIs tend to spare sexual function but can cause insomnia and restlessness. Older tricyclics are more prone to causing dry mouth, constipation, and drowsiness because they interact with a broader set of brain receptors. Many side effects are strongest in the first week or two and then diminish as your body adjusts, though sexual side effects and weight changes tend to be more persistent.
What Happens When You Stop
Stopping antidepressants abruptly can trigger a set of symptoms known as discontinuation syndrome. The symptoms follow a recognizable pattern: flu-like feelings (fatigue, headache, achiness, sweating), insomnia with vivid or disturbing dreams, nausea, dizziness or vertigo, unusual sensory experiences like electric shock-like sensations, and heightened anxiety or irritability.
These symptoms are not a sign that you’re “addicted” or that the depression is returning. They reflect your brain readjusting to functioning without the drug’s influence on neurotransmitter levels. Medications with shorter half-lives, meaning they leave your body faster, carry higher risk. Tapering gradually over six to eight weeks reduces the chance of these effects. If you’ve been on a medication for less than four weeks, tapering may not be necessary. And if symptoms become severe during a taper, the standard approach is to restart the medication and slow down the reduction schedule.
Why the Same Drug Doesn’t Work for Everyone
Depression is not a single disease with a single cause, which is why no single antidepressant works universally. One person’s depression may involve primarily serotonin pathways, another’s may center on norepinephrine or dopamine, and still another’s may involve inflammation, stress hormone dysregulation, or structural changes in the brain that no current medication directly addresses. Genetic variation also affects how quickly your body metabolizes a given drug, which influences both its effectiveness and the severity of side effects you experience.
In practice, finding the right antidepressant often involves some trial and adjustment. Roughly one-third of people respond well to the first medication they try. For those who don’t, switching to a different class that targets different neurotransmitters, combining medications, or adding a non-drug treatment like therapy often produces better results. The fact that a first attempt didn’t work says nothing about whether treatment will ultimately succeed.